Algorhythm net loss from continuing operations widens to $4.15 million in Q2 FY26; net sales more than doubled to $3.01 million

• Algorhythm reported net sales of $3.01 million for the quarter ended June 30, 2026, up 160.85% year over year.
• Net loss from continuing operations widened to $4.15 million from $1.24 million a year earlier.
• Cost of sales climbed to $3.6 million, while operating expenses rose to $2.11 million.
• Other expenses increased to $1.45 million, driven by higher interest expense and a $400,000 loss on debt extinguishment.
• Cash and restricted cash totaled $7.96 million at June 30, 2026; management flagged substantial doubt about going-concern ability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Algorhythm Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038024), on August 14, 2026, and is solely responsible for the information contained therein.